Overview

Study of Dexamethasone-Allantoin-Metronidazole (DAM) Solution in the Treatment of Post-Operative Ileus (POI)

Status:
Unknown status
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine whether Dexamethasone-Allantoin-Metronidazole (DAM) Solution can accelerate recovery of gastrointestinal function following abdominal operation when compared with a placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Beijing Bozhiyin T&S Co., Ltd.
Treatments:
Allantoin
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Metronidazole
Pharmaceutical Solutions